Britain's justice minister said on Thursday that a spike in prisoners being wrongly released from jail was unacceptable, as ...

Bryan Posthumus (R), a transphobic MAGA Republican praised for his “traditional family values,” allegedly registered an ...

Apple's second-generation iPhone Air could address one of the original model's biggest compromises, if a supply chain leak is ...

ANALYSIS: Six months into Pope Leo XIV’s pontificate, the USCCB meets to elect a new president and address challenges posed ...

Ramp reports LLCs should seek business credit cards to separate expenses, manage cash flow, and build credit, helping ...

More Americans are feeling optimistic about progress addressing illegal drugs in the United States — a major reversal since 2023 and a change largely driven by Republicans, according to a new Gallup ...

If you encounter the "Something went wrong Outlook couldn't save your account settings" error in Outlook Classic, use these ...

Discover key Q3 2025 earnings insights for REGENXBIO (RGNX): gene therapy milestones, FDA progress, financial outlook, and upcoming pivotal trial data.

Omalizumab had the greatest risk for adverse effects and dupilumab had the most favorable safety profile among biologics for patients with asthma, according to an abstract presented at the CHEST ...